Search Glycobiotech GMBH Products
Glycobiotech GmbH was founded in 1997 when we realized that materials generated during our scientific work on structure-function relationships of lipopolysaccharides (LPS) from gram-negative bacteria have a market and thus a commercial value. This holds true for highly purified LPS and derivatives thereof, as well as for polyclonal and monoclonal antibodies which are still in the center of our interest.
We study carbohydrate-antibody interactions with the aim to improve diagnosis and therapy of gram-negative infections in animals and humans as well as for a better understanding of protein-carbohydrate interactions in general which gain increasing interest in modern biology and biomedicine. Therefore, you will find for most of our products references describing studies from our group.
Primarily, we are still researchers and not business men, however, since the fight for extramural funds becomes harder we see an alternate financial resource in commercializing those items which otherwise just keep our freezers busy..
Glycobiotech has research and production facilities on the Campus of the Research Center Borstel, Leibniz-Center for Medicine and Biosciences. Please visit the website of the Research Center Borstel to see the spectrum of research activies in Borstel.
Still Need More Help?
If you have sales questions relative to particular products or to your line of research,
please contact the CEDARLANE® sales department and have all of your questions answered
in a timely and professional manner.